Home | Site Map | Contact Us | Bookmark

Following Featured Articles are available for download as PDFs:

• Cerebral blood flow changes in man by wake-promoting drug, modafinil: a randomized double blind study

• An ultra short episode of sleep is sufficient to promote declarative memory performance

• Sleep and affect in older adults: using multilevel modeling to examine daily associations

• Driver sleepiness and individual differences in preferences for countermeasures

• Relationships between affect, vigilance, and sleepiness following sleep deprivation

• Nightly Treatment of Primary Insomnia With Eszopiclone for Six Months: Effect on Sleep, Quality of Life, and Work Limitations

• The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea

• WHO includes OSAS in its 2007 report on respiratory diseases

• Sleep duration is associated with mortality

• Zolpidem extended-release shown to be safe and effective in a six-month trial

• Excessive sleepiness secondary to OSA is significantly associated with decreased work productivity

• Restless legs syndrome (RLS) is associated with coronary artery and cardiovascular disease

• Sleep Duration and Sleep Complaints and Risk of Myocardial Infarction in Middle-aged Men and Women from the General Population: The MONICA/KORA Augsburg Cohort Study

• Inflammation and Sleep in Healthy Individuals

• Two Year Reduction in Sleep Apnea Symptoms and Associated Diabetes Incidence after Weight Loss in Severe Obesity

• Long-Term Nightly Treatment with Indiplon in Adults with Primary Insomnia: Results of a Double-Blind, Placebo-Controlled, 3-Month Study

• Relationship between Hours of CPAP Use and Achieving Normal Levels of Sleepiness and Daily Functioning

The Sleep Medicine Education Institute, Inc. ("SMEI") is a non-profit corporation of the State of New Jersey and is supported by educational grants from Merck & Co. Inc., Respironics Inc., Sanofi-Aventis, Sepracor Inc. & Takeda Pharmaceuticals North America Inc.

© Copyright 2008 Sleep Medicine Education Institute, Inc. All rights Reserved. This site is maintained as an educational resource for US healthcare providers only. Use of this Web site is governed by SMEI's terms of use and privacy statement.